JPRN-UMIN000011993已完成未知
Preoperative chemoradiotherapy with irinotecan and S-1 for locally advanced rectal cancer - Preoperative chemoradiotherapy with irinotecan and S-1 for locally advanced rectal cancer
ational Defense Medical College0 个研究点目标入组 49 人开始时间: 2013年10月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 49
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients judged inappropriate for this study by the physicians
研究者
相似试验
已完成
不适用
Preoperative chemoradiotherapy with irinotecan and S-1 for locally advanced rectal cancerocally advanced rectal cancer Locally advanced anal cancerJPRN-UMIN000026306ational Defense Medical College50
进行中（未招募）
不适用
Preoperative chemoradiotherapy for advanced rectal cancerRectal or anal cancerJPRN-jRCTs031180291eno Hideki50
已完成
不适用
A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervixstage 1b2/2 cervical cancerJPRN-UMIN000000552Japanese Gynecologic Oncology Group65
进行中（未招募）
不适用
Preoperative combined radiochemotherapy for patients with newly diagnosed, primary operable and locally advanced rectal carcinoma (cT3, Nx, M0) of the lower and middle rectum - Studie R02 (95)ocally advanced rectal carcinoma (cT3, Nx, M0) of the lower and middle rectum.EUCTR2004-002358-72-ATAustrian Breast and Colorectal Cancer Study Group (ABCSG)60
已完成
1 期
Preoperative chemoradiation therapy combined with peptide vaccination for T3-pancreatic cancer: prospective phase I/II studyT3(UICC)-pancreatic cancerJPRN-UMIN000004422Department of Gastroenterological Surgery, Osaka Medical Center for cancer & Cardiovascular Diseases50